Informing the United States Medicare Drug Price Negotiation for Apixaban and Rivaroxaban: Methodological Considerations for Value Assessments Many Years After Launch
Year: 2024
Type: article
Study designs: Systematic Review, Meta-Analysis
Source: Value in Health
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funder: Arnold Ventures
OpenAlex ID: W4401170852
